Ammonium chloride and Methylprednisolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ammonium chloride (ammonium chloride) and Methylprednisolone (methylprednisolone). Common drug interactions include arthralgia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ammonium chloride and Methylprednisolone. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Ammonium chloride?

Ammonium chloride has active ingredients of ammonium chloride. eHealthMe is studying from 611 Ammonium chloride users. Check the latest studies of Ammonium chloride.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.



On Jul, 28, 2026

30 people who take Ammonium chloride and Methylprednisolone together, and have interactions are studied.

Ammonium chloride and Methylprednisolone drug interactions.

What are the common drug interactions of Ammonium Chloride and Methylprednisolone, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Blood cholesterol increased
  3. C-reactive protein increased
  4. Decreased appetite
  5. Depression
  6. Dizziness
  7. Drug ineffective
  8. Drug intolerance (drug sensitivity)
  9. Fatigue (feeling of tiredness)
  10. Fibromyalgia (a long-term condition which causes pain all over the body)

male:

  1. Chronic kidney disease
  2. Emotional distress
  3. Injury
  4. Localised infection (infection at the single location)
  5. Nerve injury
  6. Renal impairment (severely reduced kidney function)
  7. Tooth abscess (pus formation in tooth)
  8. Abdominal pain
  9. Abdominal pain upper
  10. Abscess limb (limb infection)

What are the common drug interactions of Ammonium Chloride and Methylprednisolone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease

30-39:

  1. Gestational diabetes (diabetes in pregnancy)
  2. Ketoacidosis (high concentrations of ketone bodies in blood)
  3. Renal failure (kidney dysfunction)

40-49:

  1. Chronic kidney disease
  2. Abscess limb (limb infection)
  3. Anal abscess
  4. Cellulitis (infection under the skin)
  5. Cellulitis of male external genital organ (infection of male genitals soft tissue)
  6. Cellulitis staphylococcal (a type of bacteria originated skin soft tissue infection)
  7. Emotional distress
  8. Gangrene (body tissue dies)
  9. Genital abscess (build up of pus in genital)
  10. Groin abscess (pus in groin)

50-59:

  1. Exercise tolerance decreased
  2. Gait disturbance
  3. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Pain
  7. Chronic kidney disease
  8. Renal failure (kidney dysfunction)
  9. Drug resistance (reduction in effectiveness of a drug)
  10. Leukaemoid reaction (elevated white blood cell count, or leukocytosis, that is a physiological response to stress or infection)

60+:

  1. Chronic kidney disease
  2. Pain
  3. Localised infection (infection at the single location)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Nerve injury
  6. Pancreatitis (inflammation of pancreas)
  7. Renal impairment (severely reduced kidney function)
  8. Abdominal pain
  9. Abdominal pain upper
  10. Abscess limb (limb infection)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 46.67%
  2. High Blood Pressure: 12 people, 40.00%
  3. Pain: 12 people, 40.00%
  4. Infection: 9 people, 30.00%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 26.67%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 23.33%
  7. Cough: 7 people, 23.33%
  8. High Blood Cholesterol: 6 people, 20.00%
  9. Diabetes: 6 people, 20.00%
  10. Multiple Allergies (allergy to multiple agents): 5 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ammonium chloride and Methylprednisolone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ammonium chloride and Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ammonium chloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ammonium chloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylprednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ammonium chloride and methylprednisolone (the active ingredients of Ammonium chloride and Methylprednisolone, respectively), and Ammonium chloride and Methylprednisolone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: